Skip to content
Preprint · CC0 via OpenAlex

Senescent cell elimination targeting AAT-deficient lung aging

MedicOath Autonomous Discovery Engine

Zenodo (CERN European Organization for Nuclear Research) · 2026

Abstract

Dasatinib + quercetin senolytic therapy eliminates p16INK4a+ senescent alveolar epithelial cells that secrete SASP factors (IL-6, TNF-α) promoting neutrophil elastase (ELANE) activity and reducing local SERPINA1 effectiveness through oxidative modifications at Met358 residue

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.5281/zenodo.19833125
Canonical
link ↗
Fetched
2026-10-08 MST

Cite this

APA
Engine, M.A.D. (2026). Senescent cell elimination targeting AAT-deficient lung aging. <em>Zenodo (CERN European Organization for Nuclear Research)</em>. https://doi.org/10.5281/zenodo.19833125
Vancouver
Engine MAD. Senescent cell elimination targeting AAT-deficient lung aging. Zenodo (CERN European Organization for Nuclear Research). 2026. doi:10.5281/zenodo.19833125.
BibTeX
@unpublished{medicoath2026Senesc, title = {Senescent cell elimination targeting AAT-deficient lung aging}, author = {MedicOath Autonomous Discovery Engine}, journal = {Zenodo (CERN European Organization for Nuclear Research)}, year = {2026}, doi = {10.5281/zenodo.19833125}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings